Preliminary analysis of a phase II study of Heptazyme™, a nuclease resistant ribozyme targeting hepatitis C virus (HCV) RNA.

被引：0
|
作者：
Tong, M
Schiff, E
Jensen, DM
Jacobsen, I
Eversen, G
McHutchison, JG
Aitchison, R
Gordon, GS
Babcock, SA
Enright, JH
Maloney, L
Sandberg, JA
Blatt, L
机构：
[1] Huntington Mem Hosp, Pasadena, CA USA
[2] Univ Miami, Sch Med, Miami, FL 33152 USA
[3] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[4] New York Presbyterian Hosp, New York, NY USA
[5] Univ Colorado, Hlth Sci Ctr, Denver, CO 80202 USA
[6] Scripps Clin, La Jolla, CA USA
[7] Ribozyme Pharmaceut Inc, Boulder, CO USA
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
788
引用
收藏
页码：360A / 360A
页数：1
相关论文
共 50 条
  • [21] Analysis of hepatitis C virus (HCV) RNA load in platelets of HCV-monoinfected patients receiving antiviral therapy
    do Espirito-Santo, Marcia Paschoal
    Brandao-Mello, Carlos Eduardo
    Marques, Vanessa Alves
    Lampe, Elisabeth
    De Almeida, Adilson Jose
    ANNALS OF HEPATOLOGY, 2013, 12 (03) : 373 - 379
  • [22] STUDY ON THE MOTHER TO INFANT TRANSMISSIONOF HEPATITIS C VIRUS BY COMBINED ASSAYOF ANTI-HCV AND HCV-RNA
    袁明
    陆志檬
    仇德琪
    金根娣
    赵力新
    Journal of Shanghai Second Medical University, 1999, (01) : 5 - 7
  • [23] A clinical study of the VERSANT® HCV RNA qualitative assay for the detection of hepatitis C virus (HCV) RNA in patients at risk for or suspected of active HCV infection.
    Schiff, ER
    Shiffman, ML
    McHutchison, JG
    Jackson, JB
    De Medina, MD
    Gonzalez, A
    Lane, JR
    Ivor, L
    HEPATOLOGY, 2002, 36 (04) : 347A - 347A
  • [24] Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease
    MunozGomez, R
    GarciaMonzon, C
    GarciaBuey, L
    LoLacono, O
    Borque, MJ
    GarciaSanchez, A
    Pajares, JM
    MorenoOtero, R
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (03) : 273 - 277
  • [25] Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: A population-based cohort study
    Watanabe, H
    Saito, T
    Shinzawa, H
    Okumoto, K
    Hattori, E
    Adachi, T
    Takeda, T
    Sugahara, K
    Ito, JI
    Saito, K
    Togashi, H
    Suzuki, R
    Hayashi, M
    Miyamura, T
    Matsuura, Y
    Kawata, S
    JOURNAL OF MEDICAL VIROLOGY, 2003, 71 (01) : 56 - 61
  • [26] Quantification of Hepatitis C Virus (HCV) RNA in a Multicenter Study: Implications for Management of HCV Genotype 1-Infected Patients
    Pisani, Giulio
    Cristiano, Karen
    Marino, Francesco
    Luciani, Francesca
    Bisso, Guillermo M.
    Mele, Claudio
    Adriani, Daniela
    Gentili, Giuliano
    Wirz, Maria
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (09) : 2931 - 2936
  • [27] Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy
    Tsubouchi, E
    Akbar, SMF
    Murakami, H
    Horiike, N
    Onji, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 137 (02): : 417 - 423
  • [28] An OPTIMIZE Study Retrospective Analysis for Management of Telaprevir-Treated Hepatitis C Virus (HCV)-Infected Patients by Use of the Abbott RealTime HCV RNA Assay
    Sarrazin, Christoph
    Dierynck, Inge
    Cloherty, Gavin
    Ghys, Anne
    Janssen, Katrien
    Luo, Donghan
    Witek, James
    Buti, Maria
    Picchio, Gaston
    De Meyer, Sandra
    JOURNAL OF CLINICAL MICROBIOLOGY, 2015, 53 (04) : 1264 - 1269
  • [29] Analysis of hepatitis C virus (HCV) RNA populations in the supernatant of in vivo HCV-infected human hepatocytes in primary cultures.
    Petit, MA
    Capel, F
    Mabit, H
    Dubanchet, S
    HEPATOLOGY, 1996, 24 (04) : 361 - 361
  • [30] Hepatitis C virus (HCV) infection and cryoglobulinemia: Analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology
    Schmidt, WN
    Stapleton, JT
    LaBrecque, DR
    Mitros, FA
    Kirby, PA
    Phillips, MJP
    Brashear, DL
    HEPATOLOGY, 2000, 31 (03) : 737 - 744
12345